Fahn S, Marsden CD, Calne DB. Classification and investigation of dystonia. Mov Disord. 1987. 332-58.
Grundman K. Primary torsion dystonia. Arch Neurol. 2005. 62(4):682-5.
Zacchi LF, Wu HC, Bell SL, Millen L, Paton AW, Paton JC, et al. The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia. J Biol Chem. 2014 May 2. 289(18):12727-47. [QxMD MEDLINE Link]. [Full Text].
Zech M, Gross N, Jochim A, Castrop F, Kaffe M, Dresel C, et al. Rare sequence variants in ANO3 and GNAL in a primary torsion dystonia series and controls. Mov Disord. 2014 Jan. 29(1):143-7. [QxMD MEDLINE Link].
McNaught KS, Kapustin A, Jackson T, et al. Brainstem pathology in DYT1 primary torsion dystonia. Ann Neurol. 2004 Oct. 56(4):540-7. [QxMD MEDLINE Link].
Eidelberg D, Moeller JR, Antonini A, et al. Functional brain networks in DYT1 dystonia. Ann Neurol. 1998 Sep. 44(3):303-12. [QxMD MEDLINE Link].
Ramdhani RA, Simonyan K. Primary dystonia: conceptualizing the disorder through a structural brain imaging lens. Tremor Other Hyperkinet Mov (N Y). 2013. 3:[QxMD MEDLINE Link]. [Full Text].
Kaji R, Nagako M, Urushihara R. Sensory deficits in dystonia and their significance. Fahn S, Hallet M, DeLong M, eds. Advances in Neurology: Dystonia. Philadelphia, Pa: Lippincott, Williams and Wilkins; 2004. Vol 94: 11-7.
Bara-Jimenez W, Catalan MJ, Hallett M, Gerloff C. Abnormal somatosensory homunculus in dystonia of the hand. Ann Neurol. 1998 Nov. 44(5):828-31. [QxMD MEDLINE Link].
Trost M. Dystonia update. Curr Opin Neurol. 2003 Aug. 16(4):495-500. [QxMD MEDLINE Link].
Nutt JG, Muenter MD, Aronson A, et al. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord. 1988. 3(3):188-94. [QxMD MEDLINE Link].
Fukuda H, Kusumi M, Nakashima K. Epidemiology of primary focal dystonias in the western area of Tottori prefecture in Japan: Comparison with prevalence evaluated in 1993. Mov Disord. 2006 Sep. 21(9):1503-6. [QxMD MEDLINE Link].
Defazio G, Abbruzzese G, Livrea P, Berardelli A. Epidemiology of primary dystonia. Lancet Neurol. 2004 Nov. 3(11):673-8. [QxMD MEDLINE Link].
Epidemiologic Study of Dystonia in Europe (ESDE) Collaborative Group. Sex-related influences on the frequency and age of onset of primary dystonia. Neurology. 1999 Nov 10. 53(8):1871-3. [QxMD MEDLINE Link].
Almasy L, Bressman SB, Raymond D, et al. Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann Neurol. 1997 Oct. 42(4):670-3. [QxMD MEDLINE Link].
Valente EM, Bentivoglio AR, Cassetta E, et al. DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13--36.32 in an Italian family with cranial-cervical or upper limb onset. Ann Neurol. 2001 Mar. 49(3):362-6. [QxMD MEDLINE Link].
Nemeth AH. The genetics of primary dystonias and related disorders. Brain. 2002 Apr. 125(Pt 4):695-721. [QxMD MEDLINE Link].
Shang H, Clerc N, Lang D, et al. Clinical and molecular genetic evaluation of patients with primary dystonia. Eur J Neurol. 2005 Feb. 12(2):131-8. [QxMD MEDLINE Link].
Barrett MJ, Bressman S. Genetics and pharmacological treatment of dystonia. Int Rev Neurobiol. 2011. 98:525-49. [QxMD MEDLINE Link].
Wider C, Melquist S, Hauf M, Solida A, Cobb SA, Kachergus JM, et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology. 2008 Apr 15. 70(16 Pt 2):1377-83. [QxMD MEDLINE Link]. [Full Text].
Han F, Racacho L, Lang AE, Bulman DE, Grimes DA. Refinement of the DYT15 locus in myoclonus dystonia. Mov Disord. 2007 Apr 30. 22(6):888-92. [QxMD MEDLINE Link].
Camargos S, Scholz S, Simón-Sánchez J, Paisán-Ruiz C, Lewis P, Hernandez D, et al. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol. 2008 Mar. 7(3):207-15. [QxMD MEDLINE Link].
Chouery E, Kfoury J, Delague V, Jalkh N, Bejjani P, Serre JL, et al. A novel locus for autosomal recessive primary torsion dystonia (DYT17) maps to 20p11.22-q13.12. Neurogenetics. 2008 Oct. 9(4):287-93. [QxMD MEDLINE Link].
Bressman SB, de Leon D, Brin MF, et al. Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Ann Neurol. 1989 Nov. 26(5):612-20. [QxMD MEDLINE Link].
Müller U. The monogenic primary dystonias. Brain. 2009 Aug. 132:2005-25. [QxMD MEDLINE Link].
Orosz F, Oláh J, Ovádi J. Triosephosphate isomerase deficiency: New insights into an enigmatic disease. Biochim Biophys Acta. 2009 Dec. 1792(12):1168-74. [QxMD MEDLINE Link].
Albanese A, Asmus F, Bhatia KP, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011 Jan. 18(1):5-18. [QxMD MEDLINE Link].
Cloud LJ, Jinnah HA. Treatment strategies for dystonia. Expert Opin Pharmacother. 2010 Jan. 11(1):5-15. [QxMD MEDLINE Link].
Delnooz CC, Horstink MW, Tijssen MA, van de Warrenburg BP. Paramedical treatment in primary dystonia: a systematic review. Mov Disord. 2009 Nov 15. 24(15):2187-98. [QxMD MEDLINE Link].
Bressman SB, Greene PE. Dystonia. Curr Treat Options Neurol. 2000 May. 2(3):275-285. [QxMD MEDLINE Link].
Tasker RR, Doorly T, Yamashiro K. Thalamotomy in generalized dystonia. Adv Neurol. 1988. 50:615-31. [QxMD MEDLINE Link].
Krause M, Fogel W, Kloss M, et al. Pallidal stimulation for dystonia. Neurosurgery. 2004 Dec. 55(6):1361-8; discussion 1368-70. [QxMD MEDLINE Link].
Tronnier VM, Fogel W. Pallidal stimulation for generalized dystonia: report of three cases. J Neurosurg. 2000 Mar. 92(3):453-6. [QxMD MEDLINE Link].
Vercueil L, Pollak P, Fraix V, et al. Deep brain stimulation in the treatment of severe dystonia. J Neurol. 2001 Aug. 248(8):695-700. [QxMD MEDLINE Link].
Coubes P, Echenne B, Roubertie A, et al. Treatment of early-onset generalized dystonia by chronic bilateral stimulation of the internal globus pallidus. Apropos of a case [in French]. Neurochirurgie. 1999 May. 45(2):139-44. [QxMD MEDLINE Link].
Krauss JK, Yianni J, Loher TJ, Aziz TZ. Deep brain stimulation for dystonia. J Clin Neurophysiol. 2004 Jan-Feb. 21(1):18-30. [QxMD MEDLINE Link].
Coubes P, Cif L, El Fertit H, et al. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J Neurosurg. 2004 Aug. 101(2):189-94. [QxMD MEDLINE Link].
Cif L, Vasques X, Gonzalez V, Ravel P, Biolsi B, Collod-Beroud G, et al. Long-term follow-up of DYT1 dystonia patients treated by deep brain stimulation: An open-label study. Mov Disord. 2010 Jan 8. [QxMD MEDLINE Link].
Woehrle JC, Blahak C, Kekelia K, Capelle HH, Baezner H, Grips E, et al. Chronic deep brain stimulation for segmental dystonia. Stereotact Funct Neurosurg. 2009. 87(6):379-84. [QxMD MEDLINE Link].
Lozano A, Abosch A. Pallidal stimulation for dystonia. Fahn S, Hallet M, De Long M, eds. Advances in Neurology: Dystonia. Philadelphia, Pa: Lippincott, Williams and Wilkins; 2004. Vol 94: 301-8.
Bertrand CM, Molina-Negro P. Selective peripheral denervation in 111 cases of spasmodic torticollis: rationale and results. In: Fahn S, Marsden CD, Calne DB, eds. Dystonia. Advances in Neurology. New York, NY: Raven; 1988. Vol 50: 637-43.
Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology. 1986 Feb. 36(2):160-4. [QxMD MEDLINE Link].
Balash Y, Giladi N. Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options. Eur J Neurol. 2004 Jun. 11(6):361-70. [QxMD MEDLINE Link].
Brin MF, Comella C, Jankovic J. Dystonia: Etiology, Clinical Features, and Treatment. Philadelphia, Pa: Lippincott, Williams, and Wilkins; 2004.
Fahn S, Hallet M, De Long M, eds. Advances in Neurology: Dystonia. Philadelphia, Pa: Lippincott, Williams and Wilkins; 2004. Vol 94:
FDA Requires Boxed Warning for All Botulinum Toxin Products. U.S. Food and Drug Administration. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149574.htm. Accessed: January 19, 2010.
Ford B, Greene P, Louis ED, et al. Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol. 1996 Dec. 53(12):1241-6. [QxMD MEDLINE Link].
Fuchs T, Gavarini S, Saunders-Pullman R, Raymond D, Ehrlich ME, Bressman SB, et al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet. 2009 Mar. 41(3):286-8. [QxMD MEDLINE Link].
Greene P. Baclofen in the treatment of dystonia. Clin Neuropharmacol. 1992 Aug. 15(4):276-88. [QxMD MEDLINE Link].
Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, et al. Novel THAP1 sequence variants in primary dystonia. Neurology. 2010 Jan 19. 74(3):229-38. [QxMD MEDLINE Link]. [Full Text].
Segawa M, Nomura Y. Genetics and pathophysiology of primary dystonia with special emphasis on DYT1 and DYT5. Semin Neurol. 2014 Jul. 34 (3):306-11. [QxMD MEDLINE Link].
Müller J, Wissel J, Masuhr F, Ebersbach G, Wenning GK, Poewe W. Clinical characteristics of the geste antagoniste in cervical dystonia. J Neurol. 2001 Jun. 248 (6):478-82. [QxMD MEDLINE Link].